Rapid Assessment of Potential Interventions & Drugs for Ebola (RAPIDE) - BCV

Not Applicable

• Conditions: Ebola; Ebola Virus

• Registration Number: PACTR201411000939962
• Lead Sponsor: niversity of Oxford

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-11-14
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Male and female patients 2 months of age or older
Laboratory confirmed infection with Ebolavirus infection.
Women who are lactating must agree to stop breastfeeding (a standard recommendation for all EVD patients)
Willingness to use barrier birth control for 3 months after recovery of EVD (a standard recommendation for all EVD patients)
For patients 18 years and older: the ability to provide fully informed consent or the provision of consent from the representative of a patient deemed too unwell to comprehend what is being asked of them.
For patients under 18 years: consent from a parent or guardian.

Exclusion Criteria

Any underlying disease or condition that, in the opinion of the principal investigator or treating physician, could jeopardize the participant¿s or healthcare workers safety or the participant¿s ability to comply with the protocol requirements
Patient unable to take oral IMP (e.g. severe vomiting unresponsive to anti-emetics, unconscious)
Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified